Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 17 7 2021
medline: 28 12 2021
entrez: 16 7 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

pubmed: 34270905
doi: 10.1161/CIRCEP.120.009591
doi:

Substances chimiques

ADRB1 protein, human 0
Adrenergic beta-Antagonists 0
Propanolamines 0
Receptors, Adrenergic, beta-1 0
bucindolol E9UO06K7CE

Banques de données

ClinicalTrials.gov
['NCT01970501']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e009591

Investigateurs

F Ayala-Paredes (F)
A Bakbak (A)
M L Bernier (ML)
D H Birnie (DH)
B Coutu (B)
E Crystal (E)
M W Deyell (MW)
K M Dyrda (KM)
M C Hartleib (MC)
Z W Laksman (ZW)
P Leong-Sit (P)
C A Morillo (CA)
A S Pandey (AS)
F Philippon (F)
S Vizel (S)
P Andréka (P)
Z Csanadi (Z)
G Z Duray (GZ)
T Forster (T)
G Kerkovits (G)
B Merkely (B)
A C Nagy (AC)
T Simor (T)
D Czarnecka (D)
J D Kasprzak (JD)
W J Musial (WJ)
G Raczak (G)
J Szachniewicz (J)
J K Wranicz (JK)
S Apostolović (S)
S Hinić (S)
V Miloradović (V)
D Simić (D)
G J Milhous (GJ)
A Oomen (A)
T J Romer (TJ)
L M van Vijk (LM)
P B Adamson (PB)
J D Allred (JD)
N Amjadi (N)
M M Bahu (MM)
A J Bank (AJ)
A E Berman (AE)
M A Bernabei (MA)
R S Bhagwat (RS)
L Borgatta (L)
A J Buda (AJ)
R T Cole (RT)
J L Collier (JL)
S J Compton (SJ)
O Costantini (O)
M R Costanzo (MR)
I M Dauber (IM)
M P Donahue (MP)
I Dor (I)
G F Egnacyzk (GF)
E J Eichhorn (EJ)
C C Eiswirth (CC)
S Emani (S)
G A Ewald (GA)
R C Forde-McLean (RC)
M D Gelernt (MD)
D E Haines (DE)
C A Henrikson (CA)
J M Herre (JM)
B Herweg (B)
L Ilkhanoff (L)
L R Jackson (LR)
A Lala (A)
R Lo (R)
B London (B)
B D Lowes (BD)
J A Mackall (JA)
V Malhotra (V)
F A McGrew (FA)
S Murali (S)
A Natale (A)
K R Nilsson (KR)
J Okolo (J)
M V Perez (MV)
R S Phang (RS)
R Ranjan (R)
M Y Rashtian (MY)
M J Ross (MJ)
S M Samii (SM)
T Shinn (T)
M B Shoemaker (MB)
S A Strickberger (SA)
V N Tholakanahalli (VN)
A Tzur (A)
P J Wang (PJ)
L T Younis (LT)

Auteurs

Jonathan P Piccini (JP)

Duke Clinical Research Institute & Duke University Medical Center, Durham, NC (J.P.P.).

Christopher Dufton (C)

ARCA biopharma, Inc, Westminster, CO (C.D., I.A.C., D.M., M.R.B.).

Ian A Carroll (IA)

ARCA biopharma, Inc, Westminster, CO (C.D., I.A.C., D.M., M.R.B.).

Jeff S Healey (JS)

Population Health Research Institute, McMaster University, Hamilton, ON (J.S.H., S.J.C.).

William T Abraham (WT)

Ohio State University Medical Center, Columbus (W.T.A.).

Yaariv Khaykin (Y)

Southlake Regional Health Center, Newmarket, ON (Y.K.).

Ryan Aleong (R)

University of Colorado, Aurora (R.A., M.R.B.).

Steven K Krueger (SK)

Nebraska Heart Institute, Lincoln (S.K.K.).

William H Sauer (WH)

Brigham and Women's Hospital & Harvard Medical School, Boston, MA (W.H.S.).

Stephen B Wilton (SB)

Libin Cardiovascular Institute of Alberta, University of Calgary (S.B.W.).

Michiel Rienstra (M)

University of Groningen & University Medical Center Groningen, the Netherlands (M.R., D.J.v.V.).

Dirk J van Veldhuisen (DJ)

University of Groningen & University Medical Center Groningen, the Netherlands (M.R., D.J.v.V.).

Inder S Anand (IS)

University of Minnesota, Minneapolis (I.S.A.).

Michel White (M)

Montreal Heart Institute, QC (M.W.).

A John Camm (AJ)

St. George's University of London, United Kingdom (A.J.C.).

Paul D Ziegler (PD)

Medtronic, PLC, Minneapolis, MN (P.D.Z.).

Debra Marshall (D)

ARCA biopharma, Inc, Westminster, CO (C.D., I.A.C., D.M., M.R.B.).

Michael R Bristow (MR)

ARCA biopharma, Inc, Westminster, CO (C.D., I.A.C., D.M., M.R.B.).
University of Colorado, Aurora (R.A., M.R.B.).

Stuart J Connolly (SJ)

Population Health Research Institute, McMaster University, Hamilton, ON (J.S.H., S.J.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH